Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Leukemia

  Free Subscription


Articles published in Acta Haematol

Retrieve available abstracts of 30 articles:
HTML format
Text format



Single Articles


    July 2017
  1. TIMMERMANS K, Leijte GP, Kox M, Scheffer GJ, et al
    Release of Danger-Associated Molecular Patterns following Chemotherapy Does Not Induce Immunoparalysis in Leukemia Patients.
    Acta Haematol. 2017;138:39-43.
    PubMed     Text format     Abstract available


  2. ANAGNOSTOPOULOU E, Papanastasopoulou C, Papastamataki M, Kotsiou A, et al
    Serum Hyaluronic Acid Levels Are Altered in Acute Leukemia Patients: Potential Prognostic Implications.
    Acta Haematol. 2017;138:44-51.
    PubMed     Text format     Abstract available


  3. HERNANDEZ-RIVAS JA, Gonzalez-Gascon Y Marin I
    Genetic Heterogeneity in Chronic Lymphocytic Leukemia: What Can Conventional Cytogenetics Add?
    Acta Haematol. 2017;138:31-32.
    PubMed     Text format    


    June 2017
  4. CHANG H, Kuo MC, Tang TC, Lin TL, et al
    Clinical Features and Recurrence Pattern of Perianal Abscess in Patients with Acute Myeloid Leukemia.
    Acta Haematol. 2017;138:10-13.
    PubMed     Text format     Abstract available


    May 2017
  5. PETERSON JF, Shah R, Kobrinski D
    Two Distinct BCL2 Rearrangements, Each Observed in 2 Independent Subclones, Evolving from a Founder Clone with Trisomy 12 in a Unique Case of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma.
    Acta Haematol. 2017;137:237-239.
    PubMed     Text format    


    April 2017
  6. ZHAO H, Xu L, Yang Y, Shao J, et al
    Successful Management of Decitabine prior to Full-Dose Idarubicin and Cytarabine in the Treatment of Refractory/Recurrent Acute Myeloid Leukemia.
    Acta Haematol. 2017;137:195-200.
    PubMed     Text format     Abstract available


  7. LI Y, Wang CL, Din B, Yu L, et al
    Continuing Imatinib Treatment for Chronic Myeloid Leukemia Patients Who Had Serious Adverse Events at the Onset of Therapy.
    Acta Haematol. 2017;137:158-162.
    PubMed     Text format    


  8. PTACKOVA P, Petrackova M, Hindos M, Duskova M, et al
    Intracellular Cytokines Produced by Stimulated CD3+ Cells from Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2017;137:148-157.
    PubMed     Text format     Abstract available


    January 2017
  9. QUINTELA A, Sujobert P, Callet-Bauchu E, Salles G, et al
    Ibrutinib-Induced Lymphocytosis: Cytological Features.
    Acta Haematol. 2017;137:55-57.
    PubMed     Text format    


  10. LONGU F, Fozza C, Dessi L, Longinotti M, et al
    Fludarabine and Cytarabine Combination in the Induction of Adult Patients with Acute Myeloid Leukaemia.
    Acta Haematol. 2017;137:15-16.
    PubMed     Text format    


  11. GUREVICH-SHAPIRO A, Tzadok S, Rosenberg A, Inbal A, et al
    Extended Small-Dose Platelet Transfusions in Multitransfused Hemato-Oncological Patients: A Single-Center Experience.
    Acta Haematol. 2017;137:183-190.
    PubMed     Text format     Abstract available


  12. LIANG Y, Gao J, Wu D, Li S, et al
    Long-Term Remission following Autologous Hematopoietic Cell Transplantation in a Patient with Multiple Nonleukemic Myeloid Sarcoma and a Review of the Literature.
    Acta Haematol. 2017;137:117-122.
    PubMed     Text format     Abstract available


    November 2016
  13. SHENG G, Zeng Z, Pan J, Wang Q, et al
    t(1;9)(p34;q34)/SFPQ-ABL1 Fusion in a Patient with Ph-Like Common B-Cell Acute Lymphoblastic Leukemia.
    Acta Haematol. 2016;137:40-43.
    PubMed     Text format    


    October 2016
  14. MORI N, Ohwashi-Miyazaki M, Okada M, Yoshinaga K, et al
    Translocation (9;12)(q34.1;p13.3) Resulted in ETV6-ABL1 Fusion in a Patient with Philadelphia Chromosome-Negative Chronic Myelogenous Leukemia.
    Acta Haematol. 2016;136:240-243.
    PubMed     Text format    


    September 2016
  15. BALJEVIC M, Dumitriu B, Lee JW, Paietta EM, et al
    Telomere Length Recovery: A Strong Predictor of Overall Survival in Acute Promyelocytic Leukemia.
    Acta Haematol. 2016;136:210-218.
    PubMed     Text format     Abstract available


    August 2016
  16. HULEGARDH E, Punab M, Holmberg E, Palk K, et al
    Acute de novo Leukemia in Estonia and Western Sweden 1982-2006: Positive Trend in the Survival of Acute Leukemia over 25 Years.
    Acta Haematol. 2016;136:167-173.
    PubMed     Text format     Abstract available


  17. KAMODA Y, Izumi K, Iioka F, Akasaka T, et al
    Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Is Separated into Two Subgroups Associated with Survival by BCR-ABL Fluorescence in situ Hybridization of Segmented Cell Nuclei: Report from a Single Institution.
    Acta Haematol. 2016;136:157-166.
    PubMed     Text format     Abstract available


    May 2016
  18. BYUN JM, Lee JO, Bang SM, Yu ES, et al
    8p11 Myeloproliferative Syndrome with t(7;8) Translocation Presenting as Acute Myeloid Leukemia: A Case Report and Literature Review.
    Acta Haematol. 2016;136:71-75.
    PubMed     Text format    


    April 2016
  19. YAN W, Zhang G
    Molecular Characteristics and Clinical Significance of 12 Fusion Genes in Acute Promyelocytic Leukemia: A Systematic Review.
    Acta Haematol. 2016;136:1-15.
    PubMed     Text format     Abstract available


    March 2016
  20. LI X, Zhu H, Zhang Y, Zhao W, et al
    The Time to Clearance of Peripheral Blood Blasts Predicts Complete Remission and Survival in Chinese Adults with Acute Myeloid Leukemia.
    Acta Haematol. 2016;135:217-223.
    PubMed     Text format     Abstract available


    January 2016
  21. SCHILLER GJ
    High-Intensity Induction in the Elderly.
    Acta Haematol. 2016;135:53-4.
    PubMed     Text format    


  22. FARINA M, Rossi G, Bellotti D, Marchina E, et al
    Is Having Clonal Cytogenetic Abnormalities the Same as Having Leukaemia.
    Acta Haematol. 2016;135:39-42.
    PubMed     Text format     Abstract available


  23. KAEDA J, Ringel F, Oberender C, Gresse M, et al
    Longitudinal Study to Assess the Clinical Significance of MSI2 Expression in Chronic Myeloid Leukemia Patients.
    Acta Haematol. 2016;136:62-4.
    PubMed     Text format    


  24. SANTOLERI F, Lasala R, Ranucci E, La Barba G, et al
    Medication Adherence to Tyrosine Kinase Inhibitors: 2-Year Analysis of Medication Adherence to Imatinib Treatment for Chronic Myeloid Leukemia and Correlation with the Depth of Molecular Response.
    Acta Haematol. 2016;136:45-51.
    PubMed     Text format     Abstract available


  25. AMITAI I, Leader A, Raanani P
    Adherence to Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia: The Challenge That Lies Ahead.
    Acta Haematol. 2016;136:43-4.
    PubMed     Text format    


  26. NORSWORTHY KJ, Bhatnagar B, Singh ZN, Gojo I, et al
    Myeloid Sarcoma of the Hepatobiliary System: A Case Series and Review of the Literature.
    Acta Haematol. 2016;135:241-51.
    PubMed     Text format     Abstract available


  27. ALSHIEKH-NASANY R, Douer D
    L-Carnitine for Treatment of Pegasparaginase-Induced Hepatotoxicity.
    Acta Haematol. 2016;135:208-10.
    PubMed     Text format     Abstract available


  28. SHANSHAL M, Shakespeare A, Thirumala S, Fenton B, et al
    Dasatinib-Induced T-Cell-Mediated Colitis: A Case Report and Review of the Literature.
    Acta Haematol. 2016;136:219-228.
    PubMed     Text format     Abstract available


  29. GONG D, Li W, Hu LD, Shen JL, et al
    Comparison of Clinical Efficacy of Cytarabine with Different Regimens in Postremission Consolidation Therapy for Adult t(8;21) AML Patients: A Multicenter Retrospective Study in China.
    Acta Haematol. 2016;136:201-209.
    PubMed     Text format     Abstract available


  30. ZHANG G, Dong F, Luan C, Zhang X, et al
    Overexpression of CCAAT Enhancer-Binding Protein alpha Inhibits the Growth of K562 Cells via the Foxo3a-Bim Pathway.
    Acta Haematol. 2016;136:65-70.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Leukemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: